Esophageal Catheters Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Esophageal Catheters Market is segmented by Type (Balloon Dilation Catheter, Irrigation Catheter and Pressure Monitoring Catheter), Application (Gastroesophageal Reflux Disease (GERD), Dysphagia, Chest Pain, Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Esophageal Catheters Market Size

Esophageal Catheters Market Size
Study Period: 2018 - 2028
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.2 %

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and it's growth?

Esophageal Catheters Market Analysis

The esophageal catheters market is poised to grow at a CAGR of 7.2% over the forecast period.

The COVID-19 pandemic has severely impacted the market. Since the beginning of the pandemic, there had been numerous discussions regarding the impact of COVID-19 on several areas of human health, and gastroesophageal disease was no exception. According to the study published in September 2021, titled “Assessing the genetic relationship between gastroesophageal reflux disease and risk of COVID-19 infection”, the results of an observational study conducted to investigate the possibility of a shared genetic basis between Gastroesophageal reflux disease (GERD) and COVID-19 hospitalization revealed a susceptible genetic co-relationship between GERD and risk of COVID-19 hospitalization, with magnetic resonance imaging (MRI), results indicating a possible causal relationship between the two. In addition to causing digestive symptoms, there was concern that the virus could travel beyond the gastrointestinal (GI) tract by infecting or encouraging inflammation in other organ systems, particularly the respiratory tract, via a "gut-lung axis". The gut is the body's largest immunological organ and could support colonies of rapidly replicating SARS-COV-2. Such studies and research indicate a link between COVID-19 and GERD. Hence, COVID-19 pandemic had a significant impact on the market.

The growing prevalence of chronic esophageal disorders and rising research and development activities are the major factors that are boosting the growth of the esophageal catheter market globally. For instance, as per the article “Gastroesophageal Reflux Disease” updated in July 2022 by the National Library of Medicine, GERD is one of the most common chronic gastrointestinal disorders, affecting around 20% of people in western culture each year, and is defined by the regurgitation of gastric contents into the esophagus. As a result, it is likely to propel market expansion throughout the forecast period. In addition, as per the study published in April 2022, titled "the global prevalence of oropharyngeal dysphagia in different populations: a systematic review and meta-analysis", the global prevalence rate of oropharyngeal dysphagia (OD) was assessed to be 43.8% in 2021 and Africa having the highest prevalence rate at 64.2% in 2021. Hence, the growing prevalence of gastroesophageal diseases is boosting the market growth.

The technological advancements and growing elderly populace as they are more prone to many chronic diseases are anticipated to upsurge the growth of the esophageal catheters market globally. Furthermore, product approvals, launches, partnerships, and acquisitions are also supporting the market growth. For instance, in July 2020, Allurion Technologies expanded into the Asian market with the launch of the Elipse Gastric Balloon Weight Loss Program in Hong Kong, Malaysia, and Singapore.

However, stringent regulatory approvals, poor availability of esophageal catheters in emerging nations, and the high cost of the devices are expected to hamper the esophageal catheters market growth globally.

Esophageal Catheters Industry Segmentation

As per the scope of the report, the esophageal catheter which consists of pressure sensors is passed through the patient’s nose down the esophagus and stomach. Esophageal manometry is used to measure the rhythmic muscle contractions that occur in esophagus when patient swallow is also used to measure the coordination and force of the esophageal muscles as they move food into the stomach. Esophageal manometry may be used to help diagnose Diffuse esophageal spasm, Achalasia, Scleroderma, gastroesophageal reflux disease (GERD), chest pain etc. The Esophageal Catheters Market is segmented by Type (Balloon Dilation Catheter, Irrigation Catheter and Pressure Monitoring Catheter), Application (Gastroesophageal Reflux Disease (GERD), Dysphagia, Chest Pain, Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.

By Type
Balloon Dilation Catheter
Irrigation Catheter
Pressure Monitoring Catheter
By Application
Gastroesophageal Reflux Disease (GERD)
Chest Pain
By End User
Ambulatory Surgical Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Esophageal Catheters Market Trends

This section covers the major market trends shaping the Esophageal Catheters Market according to our research experts:

Gastroesophageal Reflux Disease (GERD) Segment Holds a Significant Market Share

Gastroesophageal reflux disease encompasses numerous GERD diagnostic and therapy options. The GERD includes discomfort or a burning sensation in the upper portion of the stomach, nausea, abdominal bloating, and belching. The increasing prevalence of GERD is supporting market growth. For instance, the article “Prevalence of Gastroesophageal Reflux Disease and Associated Risk Factors in the Eastern Region, Saudi Arabia” published in November 2021, indicated that the estimated prevalence of GERD in 2021 ranged from 15% to 25%, whereas in Saudi Arabia had prevalence rate between 15% - 45.4%, Western Asia with 10% to 20%, the Middle East with 8.7% to 33.1%, and Eastern Asia reported less than 10% prevalence throughout the study. Thus, the growing prevalence of GERD diseases is expected to drive the demand for esophageal catheters, thereby driving segment growth over the forecast period.

Furthermore, various initiatives taken by private players are expected to support market growth. For instance, in August 2022, Salvo Health, a digital gastrointestinal care firm, raised USD 10.5 million in venture funding. The firm provides a virtual clinic for those suffering from chronic gut issues such as irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), dyspepsia, and small intestinal bacterial overgrowth (SIBO).

Thus, all the above-mentioned factors are expected to boost segment growth over the forecast period.

Esophageal Catheters Market 1

North America Dominates the Global Esophageal Catheters Market

The increasing prevalence of gastrointestinal diseases, favorable reimbursement policies, the aging population, and the presence of major market players are the primary factors behind the large market size in North America. In an article titled "Gastroesophageal Reflux Disease" published in the National Library of Medicine in July 2022, GERD has the highest prevalence in the United States, affecting 18.1% to 27.8% of people per year. Such a high burden of disease in the country is anticipated to demand the availability and development of advanced and effective devices. Thereby, driving the market growth in the country.

The approvals and launches are primary drivers of the segment's growth. For instance, in October 2021, Spatz Medical received the Food and Drug Administration approval for the Spatz3 Gastric Balloon, one of the first adjustable gastric balloons. These approvals are projected to increase the demand for gastric balloons and augment segment growth. Additionally, in March 2021, Apollo Endosurgery, Inc. received a breakthrough device designation from the United States Food and Drug Administration for the orbera intragastric balloon, with a focus on the indication for use in treating patients with noncirrhotic nonalcoholic steatohepatitis (NASH) with liver fibrosis and a basal metabolic index (BMI) between 30 and 40 kg/m2. Hence, such launches are expected to increase the usage of gastric balloons in the region and augment market growth.

Therefore, owing to the factors mentioned above, the market studied is anticipated to witness growth in the region.

Esophageal Catheters Market 2

Esophageal Catheters Industry Overview

Esophageal catheters market is moderately consolidated owing to the presence of many small and large market players. Some of the market players are Boston Scientific Corporation, CooperSurgical Inc, CardioCommand, Inc., EB Neuro S.p.A., Medtronic, PENNINE HEALTHCARE, Panmed US, PENTAX Medical amongst others.

Esophageal Catheters Market Leaders

  1. Boston Scientific Corporation

  2. CooperSurgical Inc

  3. CardioCommand, Inc.

  4. Medtronic

  5. EB Neuro S.p.A.

*Disclaimer: Major Players sorted in no particular order


Esophageal Catheters Market News

  • In August 2022, in Japan, Abbott has introduced the TactiFlex SE irrigation catheter. TactiFlex SE is a radiofrequency (RF) ablation catheter featuring contact force technology and a split tip electrode. For patients with unique anatomies, the catheter tip is flexible and adjusts to the curvature of the heart's wall.
  • In September 2022, Allurion launched its swallowable gastric balloon capsule for weight loss in India.

Esophageal Catheters Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Esophageal Chronic Disorders

      2. 4.2.2 Growing Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Approval

      2. 4.3.2 Poor Availability of Esophageal Catheters in Emerging regions

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 5.1 By Type

      1. 5.1.1 Balloon Dilation Catheter

      2. 5.1.2 Irrigation Catheter

      3. 5.1.3 Pressure Monitoring Catheter

    2. 5.2 By Application

      1. 5.2.1 Gastroesophageal Reflux Disease (GERD)

      2. 5.2.2 Dysphagia

      3. 5.2.3 Chest Pain

      4. 5.2.4 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Clinics

      3. 5.3.3 Ambulatory Surgical Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 CooperSurgical Inc.

      3. 6.1.3 CardioCommand, Inc.

      4. 6.1.4 EB Neuro S.p.A.

      5. 6.1.5 Medtronic PLC

      6. 6.1.6 Unisurge International Limited (PENNINE HEALTHCARE)

      7. 6.1.7 Zavation (Panmed US)

      8. 6.1.8 PENTAX Medical

      9. 6.1.9 Merit Medical Systems

      10. 6.1.10 Hamilton Medical

      11. 6.1.11 Allurion Technology

      12. 6.1.12 Charles River Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Esophageal Catheters Market Research FAQs

The Esophageal Catheters Market is studied from 2018 - 2028.

The Esophageal Catheters Market is growing at a CAGR of 7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

Boston Scientific Corporation, CooperSurgical Inc, CardioCommand, Inc., Medtronic, EB Neuro S.p.A. are the major companies operating in Esophageal Catheters Market.

Global Esophageal Catheters Industry Report

Statistics for the 2023 Global Esophageal Catheters market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Esophageal Catheters analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!